Highlights
NASDAQ: SNGX       Soligenix Inc
Last Price Today's Change   Day's Range   Trading Volume
0.99   -0.01 (1.00%)  0.975 - 1.00  28,700

Overview

 
Avg Volume (4 weeks):50,019
4 Weeks Range:0.85 - 1.10
4 Weeks Price Volatility (%):
56.00%
52 Weeks Range:0.65 - 1.39
52 Weeks Price Volatility (%):
45.95%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely BioTherapeutics and Vaccines/BioDefense. The BioTherapeutics business segment is developing a novel photodynamic therapy (SGX301) utilizing topical synthetic hypericin activated with safe visible fluorescent light for the treatment of cutaneous T-cell lymphoma whereas the Vaccines/BioDefense business segment includes development programs for RiVax, a ricin toxin vaccine candidate; OrbeShield, a GI acute radiation syndrome therapeutic candidate; and SGX943, a melioidosis therapeutic candidate.

  Be the first to like this.
 


 

4486  3499  717  224 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CHK 0.702+0.032 
 FCEL 0.81+0.265 
 AMD 37.52+0.81 
 EEM 42.76-0.33 
 ET 11.16-0.50 
 SPY 309.10+0.10 
 GE 11.29-0.13 
 BAC 32.79-0.30 
 DIS 148.72+10.14 
 XLF 29.61-0.19 
Partners & Brokers